SIP
SGHT icon

Stoneridge Investment Partners’s Sight Sciences SGHT Stock Holding History

Stoneridge Investment Partners’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-15,235
Closed -$37K – 146
2025
Q1 		$37K Hold
15,235
– – 0.03% 110
2024
Q4 		$55K Buy
+15,235
New +$69.4K 0.02% 128

Other funds holding SGHT

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Stoneridge Investment Partners's SGHT Position: Q2 2025 in Review

Stoneridge Investment Partners sold out of Sight Sciences (SGHT) in Q2 2025, closing a stake of 15,235 shares — an estimated $37K sold.

Stoneridge Investment Partners first reported a position in SGHT in Q4 2024 and held it in 2 quarters. The position peaked at $55K in Q4 2024. 79 funds tracked by Wall St. Rank hold SGHT as of Q2 2025.

  • Stoneridge Investment Partners reported no remaining Sight Sciences position as of Q2 2025 after selling out during the quarter.
  • Stoneridge Investment Partners sold 15,235 Sight Sciences shares in Q2 2025, an estimated $37K.
  • Stoneridge Investment Partners first reported a position in Sight Sciences in Q4 2024 and held it in 2 quarters.
  • Stoneridge Investment Partners's Sight Sciences position peaked at $55K in Q4 2024.
  • 79 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2025.

Based on Stoneridge Investment Partners's 13F filing for Q2 2025, filed 11 Aug 2025.